BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 7505695)

  • 1. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile.
    Meilof JF; Frohn-Mulder IM; Stewart PA; Szatmari A; Hess J; Veldhoven CH; Smeenk RJ; Swaak AJ
    Lupus; 1993 Aug; 2(4):239-46. PubMed ID: 7505695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
    Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
    Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
    Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
    J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La.
    Julkunen H; Kurki P; Kaaja R; Heikkilä R; Immonen I; Chan EK; Wallgren E; Friman C
    Arthritis Rheum; 1993 Nov; 36(11):1588-98. PubMed ID: 8240435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
    Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal lupus: bedside to bench and back.
    Buyon JP
    Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of mothers of children with complete congenital heart block.
    Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
    Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. A longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus.
    Derksen RH; Meilof JF
    Arthritis Rheum; 1992 Aug; 35(8):953-9. PubMed ID: 1642661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block.
    Taylor PV; Taylor KF; Norman A; Griffiths S; Scott JS
    Br J Rheumatol; 1988 Apr; 27(2):128-32. PubMed ID: 3284603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to SS-A 52-kDa and 60-kDa proteins and to SS-B 50-kDa protein in mothers of infants with neonatal lupus erythematosus.
    Yukiko N
    Br J Dermatol; 2000 May; 142(5):908-12. PubMed ID: 10809847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Julkunen H; Siren MK; Kaaja R; Kurki P; Friman C; Koskimies S
    Br J Rheumatol; 1995 Oct; 34(10):901-7. PubMed ID: 7582692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
    Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
    Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity to the p305 Epitope of the α1G T-Type Calcium Channel and Autoimmune-Associated Congenital Heart Block.
    Markham AJ; Rasmussen SE; Salmon JE; Martinez-Ortiz W; Cardozo TJ; Clancy RM; Buyon JP
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25994441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB.
    Julkunen H; Kaaja R; Siren MK; Mack C; McCready S; Holthöfer H; Kurki P; Maddison P
    Semin Arthritis Rheum; 1998 Oct; 28(2):97-106. PubMed ID: 9806370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
    Friedman DM; Rupel A; Glickstein J; Buyon JP
    Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of maternal autoimmune response to clinical manifestations in children with congenital complete heart block.
    Eronen M; Miettinen A; Walle TK; Chan EK; Julkunen H
    Acta Paediatr; 2004 Jun; 93(6):803-9. PubMed ID: 15244231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.